To determine whether Tau protein phosphorylation was decreased in loganin-treated 3xTg-AD mice, we evaluated the levels of pTauS396 and pTauS262 in the hippocampal brain sections by immunohistochemistry. The gene discussed is MAPT; the disease is Alzheimer disease.